Clinical Trials · NCT02637284

PCO-02 - Safety and Pharmacokinetics Trial

Name: PCO-02 - Safety and Pharmacokinetics Trial
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 1BPC-157

Phase: Phase 1
Recruitment status: Unknown
Sponsor: PharmaCotherapia d.o.o.
Enrollment: 42
Start date: Oct 2015
Locations: 1 site, Mexico
Primary endpoint: Adverse events

View BPC-157 compound reference